ATI RN
Pharmacology of CNS Drugs Questions
Question 1 of 5
A psychiatric patient taking medications develops a tremor, thyroid enlargement, and leukocytosis. The drug he is taking is most likely to be
Correct Answer: D
Rationale: In this case, the correct answer is D) Lithium. Lithium is a commonly used mood stabilizer in psychiatric patients. The symptoms described - tremor, thyroid enlargement, and leukocytosis - are classic side effects associated with lithium therapy. Tremor is a common side effect of lithium, affecting up to 70% of patients. Thyroid enlargement, specifically goiter and hypothyroidism, is also a known adverse effect of lithium, occurring in about 5-10% of patients on long-term therapy. Leukocytosis, an increase in white blood cell count, can be seen in patients taking lithium as well. The other options (A) Clomipramine, (B) Haloperidol, and (C) Imipramine are not typically associated with the specific side effects described in the question stem. Clomipramine and Imipramine are tricyclic antidepressants that do not commonly cause these particular symptoms. Haloperidol is a typical antipsychotic known for causing extrapyramidal symptoms like dystonia and akathisia, not the symptoms described. In an educational context, understanding the side effects of commonly used psychiatric medications is crucial for healthcare professionals to effectively monitor and manage patients on these medications. Recognizing the side effect profile of each drug helps in early identification and appropriate management of adverse effects, ensuring optimal patient care and safety.
Question 2 of 5
The introduction of this drug may represent a novel approach to the treatment of major depressive disorders since it appears to act as an antagonist at alpha2-adrenoceptors in the CNS.
Correct Answer: D
Rationale: The correct answer is D) Mirtazapine. Mirtazapine is a tetracyclic antidepressant that acts as an antagonist at alpha2-adrenoceptors in the CNS. This pharmacological action differentiates it from the other options provided. Amoxapine (A) is a tricyclic antidepressant with potent serotonin and norepinephrine reuptake inhibition properties, but it does not act as an alpha2-adrenoceptor antagonist. Bupropion (B) is an atypical antidepressant that primarily inhibits the reuptake of dopamine and norepinephrine with minimal effect on serotonin, so it does not fit the description provided. Citalopram (C) is a selective serotonin reuptake inhibitor (SSRI) and does not exhibit alpha2-adrenoceptor antagonist activity. Understanding the pharmacological mechanisms of action of CNS drugs is crucial in selecting the appropriate medication for treating various mood disorders. Mirtazapine's unique profile as an alpha2-adrenoceptor antagonist contributes to its efficacy in managing major depressive disorders by modulating noradrenergic neurotransmission. This question highlights the importance of recognizing specific drug actions to tailor treatment strategies effectively.
Question 3 of 5
All of the following adverse effects are associated with the use of levodopa except
Correct Answer: C
Rationale: In pharmacology of CNS drugs, understanding the adverse effects of medications is crucial for safe and effective patient care. In the case of levodopa, which is commonly used in the treatment of Parkinson's disease, it is important to differentiate between the expected adverse effects and those that are not typically associated with its use. The correct answer is C) Livedo reticularis. Livedo reticularis is a mottled reticular vascular pattern that is not a typical adverse effect of levodopa. This serves as a distractor in the question to test the student's knowledge of less common adverse effects. A) Sialorrhea is excessive salivation, a common adverse effect of levodopa due to its action on dopamine receptors in the brain. B) Orthostatic hypotension is a known adverse effect of levodopa, as it can lower blood pressure upon standing. D) Dyskinesia and dystonia are common adverse effects of long-term levodopa use, characterized by involuntary movements and muscle contractions. Educationally, this question reinforces the importance of recognizing both common and uncommon adverse effects of medications. It challenges students to differentiate between expected and unexpected responses to pharmacological interventions, promoting critical thinking and a deeper understanding of medication therapy.
Question 4 of 5
Ophthalmic agents contraindicated in glaucoma patients include which of the following substances?
Correct Answer: C
Rationale: In the context of pharmacology of CNS drugs, it is crucial for students to understand the contraindications of various medications, particularly in relation to specific conditions like glaucoma. The correct answer, option C) Decongestants, is contraindicated in glaucoma patients due to their potential to cause pupil dilation, leading to an increase in intraocular pressure which can worsen the condition. Antioxidants (option A) are not contraindicated in glaucoma patients and can actually be beneficial for eye health. Antipruritics (option B) are used to relieve itching and do not have a direct contraindication in glaucoma. Emollients (option D) are moisturizing agents and do not have a direct impact on intraocular pressure in glaucoma. Educationally, understanding contraindications of medications in specific patient populations is essential for safe and effective pharmacological practice. By grasping the rationale behind contraindications, students can make informed decisions when treating patients with complex medical conditions like glaucoma. This knowledge enhances their ability to provide optimal care and avoid potential complications associated with medication use.
Question 5 of 5
Which of the following anticonvulsants is contraindicated in patients with a history of hypersensitivity to tricyclic antidepressants?
Correct Answer: D
Rationale: In this scenario, the correct answer is D) Carbamazepine. Carbamazepine is contraindicated in patients with a history of hypersensitivity to tricyclic antidepressants due to the potential for cross-reactivity between these medications. Tricyclic antidepressants and carbamazepine share structural similarities that can lead to allergic reactions in individuals with a known hypersensitivity to tricyclic antidepressants. Option A) Phenytoin is not contraindicated in patients with a history of hypersensitivity to tricyclic antidepressants. Phenytoin is an anticonvulsant that works through a different mechanism of action compared to tricyclic antidepressants, making it a safer alternative in such patients. Option B) Ethosuximide and Option C) Acetazolamide are also not contraindicated in patients with a history of hypersensitivity to tricyclic antidepressants. These medications belong to different drug classes and do not have the same cross-reactivity risks associated with carbamazepine. In an educational context, understanding contraindications and potential drug interactions is crucial for healthcare professionals, especially when prescribing medications for patients with complex medical histories. This knowledge helps prevent adverse drug reactions and ensures safe and effective pharmacological treatment. By knowing the contraindications of specific drugs, healthcare providers can make informed decisions to optimize patient care and outcomes.